论文部分内容阅读
目的:探究肝动脉化疗栓塞介入治疗对肝癌的临床疗效。方法:对我院2010年至2013年收治的30例肝癌患者根据病情进行化疗和化疗栓塞的方式进行治疗,并对其疗效进行随访观察,根据患者预后情况做出评价。结果:治疗结果统计显示患者生存率上升,66.7%病例临床症状缓解,70%肿瘤缩小,63.3%血甲胎蛋白(AFP)下降,疗效确切,安全性高。结论:肝动脉化疗栓塞术可有效治疗和控制肝癌病患病情,安全可靠,副作用少,延长肝癌患者生存期和生存质量,是重要的肝癌治疗手段,临床应用意义重大。
Objective: To investigate the clinical effect of transcatheter arterial chemoembolization on liver cancer. Methods: Thirty patients with HCC treated in our hospital from 2010 to 2013 were treated with chemotherapy and chemoembolization. The curative effect was observed and followed up according to the prognosis of the patients. Results: The results of treatment showed that the survival rate of patients increased, 66.7% of patients with clinical symptoms alleviated, 70% of the tumor shrinks, 63.3% of blood serum alpha-fetoprotein (AFP) decreased, the curative effect is exact and safe. Conclusion: Transcatheter arterial chemoembolization can effectively treat and control the patients with hepatocellular carcinoma, which is safe, reliable and has few side effects. It is an important treatment for hepatocellular carcinoma to extend the survival and quality of life of patients with hepatocellular carcinoma. The clinical application is of great significance.